SER · Serina Therapeutics, Inc. · Documents
$1.74
+0.02 (+1.16%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that our existing cash and cash equivalents are not expected to be sufficient to fund our operations for the 12 months following the issuance of our unaudited condensed consolidated financial statements for the period ended June 30, 2026, and that substantial doubt about our ability to continue as a going concern continues to exist.”View the 10-Q filed Aug 13, 2026
Market Cap
$43.69M
Shares
25.40M
Volume · Oct 19
1696
Avg daily vol (3M)
63.97K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-10-09 | 2026-10-05 | |
| 8-K | — | 2026-09-09 | — | |
| 8-K | — | 2026-08-27 | 2026-08-21 | |
| S-1 | — | 2026-08-24 | — | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 8-K | — | 2026-07-23 | 2026-07-19 | |
| 8-K | — | 2026-07-22 | — | |
| 8-K | — | 2026-06-24 | 2026-06-17 | |
| S-3 | — | 2026-05-22 | — | |
| 10-Q | — | 2026-05-14 | 2026-03-31 | |
| 8-K | — | 2026-05-14 | — | |
| DEFA14A | — | 2026-04-28 | — | |
| DEF 14A | — | 2026-04-27 | — | |
| 8-K | — | 2026-04-21 | 2026-04-15 | |
| PRE 14A | — | 2026-04-17 | — | |
| 10-K/A | — | 2026-03-27 | 2025-12-31 | |
| 8-K | — | 2026-03-25 | — | |
| 10-K | — | 2026-03-25 | 2025-12-31 | |
| 8-K | — | 2026-03-23 | 2026-03-17 | |
| S-3 | — | 2026-01-30 | — | |
| 8-K | — | 2026-01-28 | 2026-01-27 | |
| 8-K | — | 2026-01-15 | 2026-01-09 | |
| 8-K | — | 2025-12-10 | — | |
| 8-K | — | 2025-11-13 | — | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 8-K | — | 2025-11-12 | 2025-11-07 | |
| 8-K | — | 2025-11-03 | — | |
| DEFR14A | — | 2025-10-27 | — | |
| 8-K | — | 2025-10-06 | — | |
| DEFA14A | — | 2025-09-26 | — | |
| DEF 14A | — | 2025-09-26 | — | |
| 8-K | — | 2025-09-15 | 2025-09-09 | |
| PRE 14A | — | 2025-09-15 | — | |
| 8-K | — | 2025-09-09 | — | |
| 8-K | — | 2025-08-25 | — | |
| 8-K | — | 2025-08-22 | 2025-08-18 | |
| 10-Q | — | 2025-08-11 | 2025-06-30 | |
| 8-K | — | 2025-08-11 | — | |
| 8-K | — | 2025-07-29 | — | |
| 8-K | — | 2025-07-01 | — | |
| 8-K | — | 2025-05-22 | — | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| 8-K | — | 2025-05-08 | — | |
| 8-K | — | 2025-04-29 | 2025-04-25 | |
| S-3 | — | 2025-04-18 | — | |
| 8-K | — | 2025-04-15 | — | |
| 8-K | — | 2025-04-14 | 2025-04-08 | |
| 8-K | — | 2025-04-07 | — | |
| S-3 | — | 2025-04-02 | — |
Showing 1–50 of 199 filings